Met Life Investment Management, LLC Alector, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 50,369 shares of ALEC stock, worth $205,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,369
Previous 50,369
-0.0%
Holding current value
$205,001
Previous $228,000
3.07%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ALEC
# of Institutions
167Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$22.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$18.9 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$17.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$11.1 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $336M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...